Il y a 7 années
"The Patent Office has Spoken: What does it Mean for CRISPR in Europe?"
Tags : brevet, Broad Institute, Caribou Biosciences, CRISPR, CRISPR Therapeutics, Editas Medicine, innovation thérapeutique, Intellia Therapeutics, médecine, propriété industrielle, propriété intellectuelle, Royaume-Uni, santé, University of California Berkeley, USPTO - United States Patent and Trademark Office
|